Provision of Sequencing Equipment and Consumables

A Contract Award Notice
by GUY'S AND ST THOMAS' NHS FOUNDATION TRUST

Source
Contracts Finder
Type
Contract (Products)
Duration
2 year
Value
£376K
Sector
HEALTH
Published
22 Apr 2024
Delivery
31 Mar 2024 to 31 Mar 2026
Deadline
27 Mar 2024 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers
Guys & St Thomas NHS Trust
Oxford Nanopore Technologies
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

Description

Guys and St Thomas's NHS Foundation Trust (GSTT) has been awarded Funding from NHS England (NHSE) and the Department of Science, Innovation and Technology (the "Funders") for the financial years 2023/24 and 2024/25 as the lead provider for the delivery of the Respiratory Metagenomic Clinical Service Development Programme (the 'Project'), from Oxford Nanopore Technologies PLC. The Project is a pilot based on patented nanopore based sequencing technology and therefore this contract notice is issued under Regulation 32 (a) of the PCR 2015. The Project aims to deliver a national respiratory metagenomics (RMg) pilot clinical service with an integrated biosecurity surveillance purpose, as a world-first programme to combine effective infectious disease management with rapid emerging pathogen detection and notification.

Award Detail

1 Oxford Nanopore Technologies (None)
  • Value: £376,110

CPV Codes

  • 33140000 - Medical consumables
  • 33190000 - Miscellaneous medical devices and products

Reference

Domains